1-4 of 4
Sowmya Parampalli Yajnanarayana
Close
Sort by
Journal Articles

The E3 Ubiquitin Ligase Cbl-b Limits Nascent Th9 Differentiation

Isabelle Cornez, Sowmya Parampalli Yajnanarayana, Natascha Hermann-Kleiter, Stefan Ulrich Schmidt, Peter Brossart, MD, Natalio Garbi, Gottfried Baier, Dominik Wolf, MD
Journal: Blood
Blood (2015) 126 (23): 2222.
https://doi.org/10.1182/blood.V126.23.2222.2222
Published: 2015
Journal Articles

The JAK Inhibitor Ruxolitinib Substantially Affects NK Cells in MPN Patients

Kathrin Schönberg, PhD, Janna Rudolph, Maria Vonnahme, Isabelle Cornez, PhD, Sowmya Parampalli Yajnanarayana, Walter Verbeek, MD, Steffen Koschmieder, MD, Tim H. Brümmendorf, MD, Peter Brossart, MD, Annkristin Heine, MD, Dominik Wolf, MD
Journal: Blood
Blood (2014) 124 (21): 3169.
https://doi.org/10.1182/blood.V124.21.3169.3169
Published: 2014
Journal Articles

CD4 + T Cell Functions Are Potently Suppressed By The Janus Kinase 1/2 (JAK1/JAK2) Inhibitor Ruxolitinib

Sowmya Parampalli Yajnanarayana, Isabelle Cornez, PhD, Annkristin Heine, MD, Peter Brossart, MD, Dominik Wolf, MD
Journal: Blood
Blood (2013) 122 (21): 2281.
https://doi.org/10.1182/blood.V122.21.2281.2281
Published: 2013
Journal Articles

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, Stephanie Wallner, Sowmya Parampalli Yajnanarayana, Christian Kurts, Dominik Wolf, Peter Brossart
Journal: Blood
Blood (2013) 122 (7): 1192–1202.
https://doi.org/10.1182/blood-2013-03-484642
Published: 2013
Includes: Supplemental data